Review Article
Advances of Stem Cell Therapeutics in Cutaneous Wound Healing and Regeneration
Table 1
Overview of stem cell-based therapies for cutaneous wound management in vivo and their mechanism of action.
| Wound model | Type of cell therapy | Regenerative mechanisms | Reference |
| Excisional wound splinting model/Balb/C mice | BM-MSC | Recruitment of macrophages and endothelial lineages by paracrine factors | [124] | Excisional wound splinting model/diabetic mice | BM-MSC | Differentiation and angiogenesis | [129] | Excisional wound splinting model/C57BL/6 J mice | GMSC | Immunomodulation, M2 macrophage polarization | [118] | Full-thickness excisional wound/STZ-induced diabetic rat | ASC | Differentiation and vasculogenesis | [130] | Full-thickness excisional wound/STZ-induced diabetic mice | Human blood-derived CD34+ cells | Vasculogenesis | [103] | Limb ischemia and wounding/STZ-induced diabetic mice | Human fetal aorta-derived CD133+ cells | Paracrine stimulation of angiogenesis and activation of Wnt signaling | [105] | Full-thickness excisional wound in NOD/SCID mice | Nanofiber-expanded cord blood-derived CD34+ cells | Fibroblast proliferation and enhancement of collagen deposition and decreased MMP expression | [101] | Full-thickness excisional wound in NOD/SCID mice | Nanofiber-expanded cord blood-derived CD34+ cells | Immunomodulation, angiogenesis | [102] |
|
|
BM-MSC: bone marrow-derived mesenchymal stem cells; GMSC: human gingiva-derived MSC; STZ: streptozotocin; ASC: adipose-derived stem cells.
|